Tamsulosin as Adjunctive Therapy After Extracorporeal Shock Wave Lithotripsy for Renal Stones
Status:
Completed
Trial end date:
2016-12-31
Target enrollment:
Participant gender:
Summary
Urolithiasis is a common health problem worldwide affecting approximately 10% of the
population at some stage in their lives. The aim of this study is to evaluate the efficacy of
adjuvant treatment with tamsulosin for improving the stone-free rate after a single session
of extracorporeal shock wave lithotripsy (ESWL) in the treatment of radiopaque kidney stones.